Maher Albitar

Maher Albitar

Director Ejecutivo en Genomic Testing Cooperative LCA .

69 años
Consumer Services
Health Services
Commercial Services

Perfil

Maher Albitar is the founder of Genomic Testing Cooperative LCA, which was founded in 2018.
He held the position of Chief Executive & Medical Officer.
Dr. Albitar's former jobs include Director at Health Discovery Corp.
from 2010 to 2012, Director at Associated Diagnostics Pathologists, Inc. in 2011, Chief Medical Officer & Senior Vice President at NeoGenomics, Inc. from 2012 to 2018, and Chief of Research & Development at Quest Diagnostics Nichols Institute, Inc. from 2003 to 2010.
Dr. Albitar also held the title of Professor at The University of Texas M.D.
Anderson Cancer Center.
Dr. Albitar received a doctorate degree from Damascus University in 1979.

Cargos activos de Maher Albitar

EmpresasCargoInicio
Genomic Testing Cooperative LCA Director Ejecutivo 01/11/2018
Todos los cargos activos de Maher Albitar

Antiguos cargos conocidos de Maher Albitar.

EmpresasCargoFin
NEOGENOMICS, INC. Director Técnico/Científico/I+D 01/10/2018
HEALTH DISCOVERY CORPORATION Director Técnico/Científico/I+D 15/04/2011
Associated Diagnostics Pathologists, Inc. Director/Miembro de la Junta 01/01/2011
Director Técnico/Científico/I+D 01/04/2010
Corporate Officer/Principal -
Ver el detalle de la experiencia de Maher Albitar.

Formación de Maher Albitar.

Damascus University Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Maher Albitar.

Relaciones

43

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
NEOGENOMICS, INC.

Health Services

HEALTH DISCOVERY CORPORATION

Technology Services

Empresas privadas4

Commercial Services

Consumer Services

Associated Diagnostics Pathologists, Inc.

Genomic Testing Cooperative LCA

Ver las conexiones de la empresa
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA